Study Supports HCV RNA Test at Age 2-6 Months for Perinatally Exposed Infants
“Testing infants known to be perinatally exposed to hepatitis C at 2 to 6 months of age with a single HCV RNA test would reduce costs and improve health outcomes, according to a recent study. The study, published in the Journal of Pediatrics, evaluated 4 testing strategies using a decision-tree framework with a Markov disease progression model to estimate cost, quality-adjusted life years and disease sequelae.”
Assessing ELF Score Over Time in Contemporary HIV and HCV Treatment
“For a study, researchers sought to understand the trajectory of liver fibrosis in individuals with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) coinfection in the era of contemporary HIV and HCV therapy. They assessed three biomarkers of liver fibrosis: Enhanced Liver Fibrosis (ELF) score, aspartate transaminase-to-platelet ratio index (APRI), and Fibrosis-4 (FIB-4) in 116 women over 4 years.”
Effort to eradicate Hepatitis C
“Tracy City Free Clinic has partnered with Southeast Cumberland Community Fund and the Gilead Corporation to provide free testing and treatment for hepatitis C.”
New Model Risk Factors for HIV in Women Include Pregnancy, Hepatitis C, and Substance Use
“Model produces information that can lead to individual providers identifying women who may need more targeted and more frequent HIV testing or be good candidates for preexposure prophylaxis.”
Precision NanoSystems And Aurora Vaccines Join Forces To Accelerate The Development Of Vaccine Candidate For Hepatitis C Virus
“Global leader in non-viral delivery of genomic medicines, Precision NanoSystems (PNI), entered into a strategic collaboration agreement with Aurora Vaccines to accelerate the development and manufacture of its Hepatitis C vaccine candidate. PNI will share its expertise in the development of the RNA payload platform and its proprietary lipid nanoparticle (LNP) platforms to help bring Aurora’s RNA-LNP vaccine candidate for the prevention of Hepatitis C virus (HCV) infection to a Phase I clinical trial.”
Outcomes of Radiation Segmentectomy for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease versus Chronic Viral Hepatitis
“Conclusion: Although NAFLD and HCV are associated with different mechanisms of liver injury, patients with early-stage HCC treated with radiation segmentectomy achieve comparable outcomes.”
